-+ 0.00%
-+ 0.00%
-+ 0.00%

AGENUS ANNOUNCES FIRST PATIENT ENROLLED IN GLOBAL PHASE 3 BATTMAN TRIAL OF BOT+BAL IMMUNOTHERAPY COMBINATION IN MSS OR PMMR METASTATIC COLORECTAL CANCER

Reuters·04/01/2026 11:30:00

Please log in to view news